Table 1 Clinical characteristics of patients.

From: The effect of thyroid cancer on the survival of patients with digestive system tumors using SEER database

Variables

DST-only (n = 518,901)

TC-1st (n = 801)

P-value

DST-1st (n = 744)

P-value

Sex

  

< 0.001

 

< 0.001

Male

300,767(58.0%)

250(31.2%)

 

299(40.2%)

 

Female

218,134(42.0%)

551(68.8%)

 

445(59.8%)

 

Age

64(55–73)

63(53-71.5)

0.058

58(51–64)

< 0.001

Race

  

0.036

 

0.001

White

397,982(76.7%)

639(79.8%)

 

594 (79.8%)

 

Black

64,609(12.5%)

76(9.5%)

 

60(8.1%)

 

Other

56,310(10.9%)

86(10.7%)

 

90(12.1%)

 

Grade

  

< 0.001

 

< 0.001

Grade I

49,945(9.6%)

92(11.5%)

 

101(13.6%)

 

Grade II

235,849(45.5%)

323(40.3%)

 

378 (50.8%)

 

Grade III

102,223(19.7%)

129(16.1%)

 

109(14.7%)

 

Grade IV

8852(1.7%)

7(0.9%)

 

12(1.6%)

 

Unknown

122,032(23.5%)

250(31.2%)

 

144(19.4%)

 

Summary stage

  

< 0.001

 

< 0.001

Localized

180,247(34.7%)

357(44.6%)

 

351(47.2%)

 

Regional

180,631(34.8%)

254(31.7%)

 

303(40.7%)

 

Distant

135,127(26.0%)

167(20.8%)

 

70(9.4%)

 

Unknown

22,896(4.4%)

23(2.9%)

 

20(2.7%)

 

Histology

  

0.662

 

0.011

Adenocarcinoma

377,994 (72.8%)

589(73.5%)

 

573 (77.0%)

 

Other

140,907(27.2%)

212 (26.5%)

 

171 (23.0%)

 

Surgery

  

0.002

 

0.002

Yes

354,458(68.3%)

587 (73.3%)

 

685 (92.1%)

 

No

164,443(31.7%)

214 (26.7%)

 

59 (7.9%)

 

Radiation

  

0.006

 

0.469

Yes

93,734(18.1%)

115(14.4%)

 

142(19.1%)

 

None/Unknown

425,167(81.9%)

686(85.6%)

 

602(80.9%)

 

Chemotherapy

  

0.038

 

0.35

Yes

236,634(45.6%)

336(41.9%)

 

352(47.3%)

 

None/Unknown

282,267(54.4%)

465(58.1%)

 

392(52.7%)

 

Marital status

  

0.006

 

< 0.001

Married

304,407(58.7%)

508(63.4%)

 

483(64.9%)

 

Not married

214,494(41.3%)

293(36.6%)

 

261(35.1%)

 

The primary site

  

< 0.001

 

< 0.001

Esophagus

31,302(6.0%)

23(2.9%)

 

16(2.2%)

 

Stomach

58,509(11.3%)

104(13.0%)

 

61(8.2%)

 

Small intestine

16,040(3.1%)

46(5.7%)

 

48(6.5%)

 

Colon

224,388(43.2%)

366(45.7%)

 

374(50.3%)

 

Rectum

107,103(20.6%)

157(19.6%)

 

199(26.7%)

 

Liver

59,231(11.4%)

75 (9.4%)

 

33 (4.4%)

 

Pancreas

22,328(4.3%)

30(3.7%)

 

13 (1.7%)

 

Survival months

43(10–103)

54(19-94.5)

0.474

127(81-180.75)

< 0.001

Vital statu

  

< 0.001

 

< 0.001

Alive

174,177(33.6%)

416(51.9%)

 

513(69.0%)

 

Death

344,724(66.4%)

385(48.1%)

 

231(31.0%)

 

Cause of death

  

< 0.001

 

< 0.001

Alive

174,177(33.6%)

416(51.9%)

 

513(69.0%)

 

Digestive

199,857(38.5%)

197(24.6%)

 

102(13.7%)

 

Other

144,717(27.9%)

188(23.5%)

 

129(17.3%)

 
  1. TC, thyroid cancer; DST, digestive system tumors; TC-1st, thyroid cancer was diagnosed first, followed by subsequent diagnosis of digestive system tumors; DST-1st, digestive system tumors was diagnosed first, followed by subsequent diagnosis of thyroid cancer.